Finance entity
All 1 tracked stories fall under one category: earnings. Cibus Inc is most often covered alongside Trevi Therapeutics Inc, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 6.4.
Last mentioned: Mar 18, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: earnings. Cibus Inc is most often covered alongside Trevi Therapeutics Inc, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 6.4. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. Cibus Inc appears in 1 tracked Finance story from March 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 114 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Cibus Inc. Shared-story counts are live from our verified record — not editorial picks.
Trevi Therapeutics and Cibus Inc reported Q4 2025 results, highlighting a period of critical strategic execution. While Trevi outperformed earnings expectations amid clinical progress, Cibus continues to balance technological milestones against persistent financial headwinds.
Cibus Inc is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
